Cargando…
Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase
Xanthine oxidoreductase is a metalloenzyme that catalyzes the final steps in purine metabolism by converting hypoxanthine to xanthine and then uric acid. Allopurinol, an analog of hypoxanthine, is widely used as an antigout drug, as xanthine oxidoreductase-mediated metabolism of allopurinol to oxypu...
Autores principales: | Sekine, Mai, Okamoto, Ken, Pai, Emil F., Nagata, Koji, Ichida, Kimiyoshi, Hille, Russ, Nishino, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511816/ https://www.ncbi.nlm.nih.gov/pubmed/37625592 http://dx.doi.org/10.1016/j.jbc.2023.105189 |
Ejemplares similares
-
Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase
por: Sekine, Mai, et al.
Publicado: (2021) -
Mutations Associated with Functional Disorder of Xanthine Oxidoreductase and Hereditary Xanthinuria in Humans
por: Ichida, Kimiyoshi, et al.
Publicado: (2012) -
The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells
por: Kusano, Teruo, et al.
Publicado: (2022) -
Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase
por: Okamoto, Ken, et al.
Publicado: (2013) -
Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation
por: Orriss, Isabel R., et al.
Publicado: (2016)